Irwin Shelub, MD in Creston, CA - Internal Medicine

Irwin Shelub, MD is a Internal Medicine - Pulmonary Disease physician based in Creston, California. Irwin Shelub is licensed to practice in California (license number C36888) and his current practice location is 4975 Iron Springs Rd, Creston, California. He can be reached at his office (for appointments etc.) via phone at (650) 520-0635.

NPI number for Irwin Shelub is 1104855246 and his current mailing address is 4975 Iron Springs Rd, Creston, California. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1104855246.

Contact Information

	Irwin Shelub, MD
	4975 Iron Springs Rd, Creston, CA 93432-9794
	(650) 520-0635
	Not Available

Physician's Profile

Full Name	Irwin Shelub
Gender	Male
Speciality	Internal Medicine - Pulmonary Disease
Location	4975 Iron Springs Rd, Creston, California
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1104855246
Provider Enumeration Date: 07/01/2006
Last Update Date: 01/05/2017

Medical Identifiers

Medical identifiers for Irwin Shelub such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1104855246	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207RP1001X	Internal Medicine - Pulmonary Disease	C36888 (California)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Irwin Shelub is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Irwin Shelub, MD 4975 Iron Springs Rd, Creston, CA 93432-9794 Ph: (650) 520-0635	Irwin Shelub, MD 4975 Iron Springs Rd, Creston, CA 93432-9794 Ph: (650) 520-0635

News Archive

Cerulean initiates CRLX101 Phase 2 trial in non-small cell lung cancer

Cerulean Pharma Inc., a leader in designing and developing tumor-targeted nanopharmaceuticals, today announced the dosing of the first patients with CRLX101 in a randomized, controlled non-small cell lung cancer (NSCLC) Phase 2 clinical trial.

inSleep Health receives FDA clearance for Cloud9 Anti-Snoring System

inSleep Health announced today that it has received 510(K) clearance for the company's Cloud9 Anti-Snoring System. The indication for use is to reduce or eliminate simple snoring in adults. Cloud9 is a prescription device for home use. This is the first clinically proven device, using continuous low positive airway pressure, specifically labeled to treat simple snoring.

Researchers measure the brain activity in infants

Do infants only start to crawl once they are physically able to see danger coming? Or is it that because they are more mobile, they develop the ability to sense looming danger? According to Ruud van der Weel and Audrey van der Meer, from the Norwegian University of Science and Technology in Trondheim, infants' ability to see whether an object is approaching on a direct collision course, and when it is likely to collide, develops around the time they become more mobile. Their findings have just been published online in the Springer journal Naturwissenschaften.

COVID-19 in pregnancy could be less severe than previously thought: A Danish case study

A reassuring study by researchers in Denmark indicates that while 5% of pregnant women with COVID-19 may require hospitalization, severe maternal and neonatal outcomes are rare.

CT scans increase risk of radiation-induced cancer in young children, study finds

According to a study of seven U.S. healthcare systems, the use of computed tomography scans of the head, abdomen/pelvis, chest or spine, in children younger than age 14 more than doubled from 1996 to 2005, and this associated radiation is projected to potentially increase the risk of radiation-induced cancer in these children in the future, according to a study published Online First by JAMA Pediatrics, a JAMA Network publication.

Irwin Shelub, MD - Internal Medicine in Creston, CA